Nouvelle déclaration d'incident
No de la demande: 2011-0833
Numéro de référence du titulaire d'homologation: PROSAR Case 1-24400165
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Crop Protection Canada, Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez un animal domestique
Pays: UNITED STATES
État: MISSOURI
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Demand (non-specific)
Liquide
Oui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Inconnu
Professionnel de la santé
Cat / Chat
Domestic shorthair
1
Femme
5
8
lbs
Inconnu
Unknown / Inconnu
>2 hrs <=8 hrs / > 2 h < = 8 h
Système
Persisted until death
Oui
Inconnu
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
1-24400165- the reporter, a veterinary technician, indicates an animal in their care had been exposed to an insecticide containing the active ingredient Lambda-Cyhalothrin. She indicates the product was sprayed in the pet owners home by a commercial pest control operator the night prior to presentation and initial contact with the registrant. No information is available about the rate of application. It is not known what re-entry interval was observed and no discreet exposure episode was observed. The pet owner described the development of abnormal behavior the night of application in their five year eight pound female domestic shorthair cat. The owner described the animal as mopey, hiding and refusing food. The morning after application the animal was found struggling for breath at which point the animal presented to the veterinarian. The reporter asked about potential harm at the point of initial contact with the registrant. She reported no findings by the veterinarian attending the animal. The caller was advised the product was typically diluted by commercial pest control operators conferring predominantly an irritant effect to body surfaces exposed. The caller was advised nonspecific signs seen in the animal were not consistent with the toxicity profile of the active ingredient. The caller was advised of the class of the active ingredient and treatment protocols employed in overdosage scenarios. On routine follow up the reporter indicated the animal had died two days following the initial contact with the registrant. The animal had been described as non responsive and twitching the day following initial contact. The reporter described the animal as comatose. Treatments described included fluid therapy, B12, and B Complex vitamins. It is unknown what diagnostic may have been run. No further information is available
Mort